387 results
Page 3 of 20
424B3
xanrzw
27 Dec 21
Prospectus supplement
5:01pm
8-K
EX-10.1
4kwcjktuk 07
24 Nov 21
Seelos Therapeutics Announces Acquisition of an Exclusive License of iX Biopharma’s Proprietary Wafer-Based Delivery Platform for Sublingual Ketamine
8:20am
8-K
EX-10.1
k4g utzmpda
24 Nov 21
Entry into a Material Definitive Agreement
7:27am
8-K
EX-4.1
vpuol37msdylrzaldv
24 Nov 21
Entry into a Material Definitive Agreement
7:27am
8-K
umsfym1
2 Sep 21
Seelos Therapeutics Announces Senior Management Appointments
4:01pm
424B5
d0x5x0kjer430
21 May 21
Prospectus supplement for primary offering
12:00am
424B5
sgmycorqv4i
19 May 21
Prospectus supplement for primary offering
4:08pm